Blood bank issues associated with red cell exchanges in sickle cell disease
- 1 December 2006
- journal article
- review article
- Published by Wiley in Journal of Clinical Apheresis
- Vol. 21 (4) , 271-273
Abstract
Sickle cell disease (SCD) patients are prone to develop complications that include stroke, acute chest syndrome, and other crises. Some of these complications require chronic transfusion therapy or red cell exchange (RCE), either for therapeutic or prophylactic reasons. Due to a discrepancy of red cell antigens between African Americans and Caucasians (majority blood donors), the incidence of alloantibody formation is very high, which makes it difficult to find compatible red cell units, especially for urgent RCE. Some of the above conditions require immediate oxygen delivery to the tissues. Thus, SCD patients undergoing RCE should receive red blood cells with special attributes that include matching for Rh and Kell blood group antigens; RBCs should be fresh in order to provide (1) immediate oxygen delivery and (2) longer surviving cells to reduce the interval between RCE. Also, these units should be pre‐storage leukoreduced to prevent febrile non‐hemolytic reactions and screened for sickle cell traits to avoid transfusing red cells containing HbS. This requires a concerted effort between the apheresis unit, the local blood bank, and the central blood supplier. J. Clin. Apheresis 21:271–273, 2006Keywords
This publication has 10 references indexed in Scilit:
- Adverse effects in blood donors after whole‐blood donation: you find what you look for!Transfusion, 2004
- Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for ApheresisTransfusion, 2003
- The Role of Red Blood Cell Exchange Transfusion in the Treatment and Prevention of Complications of Sickle Cell DiseaseTherapeutic Apheresis, 2002
- Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population studyThe Lancet, 2001
- Introduction to the Third Special Issue: Clinical Applications of Therapeutic ApheresisJournal of Clinical Apheresis, 2000
- Blood Transfusion in Sickle Cell DiseaseVox Sanguinis, 1995
- Effects of AS‐3 nutrient‐additive solution on 42 and 49 days of storage of red cellsTransfusion, 1987
- The membrane and the lesions of storage in preserved red cellsTransfusion, 1985
- Relationship of post‐transfusion viability to deformability of stored red cellsBritish Journal of Haematology, 1983
- Effect of pH on Preservation of Red Cell ATP*Transfusion, 1965